Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer by Satomi Watanabe, Kimio Yonesaka, Junko Tanizaki, Yoshikane Nonagase, Naoki Takegawa, Koji Haratani, Hisato Kawakami, Hidetoshi Hayashi, Masayuki Takeda, Junji Tsurutani, Kazuhiko Nakagawa

Subjects: “…heregulin (HRG)…”
Get full text

Information contracting tools in a cancer specialist unit:the role of Healthcare Resource Groups (HRGs) by Carol Marlow, Hugh Preston

Subjects: Get full text